https://www.avient.com/sites/default/files/2023-01/Disinfectant Resistant Trilliant and Versaflex HC Materials Program Bulletin_0.pdf
Designed for two-
shot injection molding and formulated for the
appropriate substrate, these medical-grade TPEs
are compatible with rigid PVC, copolyesters, all
PC alloys, ABS, TPUs and PEI substrates.
https://www.avient.com/sites/default/files/2021-06/plastisol-storage-handling-technical-bulletin.pdf
Storage and Handling of Vinyl Plastisols
A vinyl plastisol is a liquid dispersion of
polyvinyl chloride (PVC) resins, plasticizers, and
miscellaneous additives.
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-final.pdf
VersaflexTM PF
Versaflex PF
VOC
Versaflex PF
VERSAFLEX PF
VOC
39 LDPE / 13 Versaflex PF
VERSAFLEX PF
39 LDPE / 13 Versaflex PF
N
/
2
5
m
m
N
/
2
5
m
m
F = 25 ° C 7 I = 25 ° C 20
MD6741 / MD6700
VERSAFLEX PF
TM
+86 021 60284888
www.avient.com
VERSAFLEX™ PF
1 CF6751 PP
2 2420K LDPE
Versaflex™ PF
MD6727
Versaflex™ PF
MD6741
Versaflex™ CF
6751
Versaflex™ PF
MD6649
Versaflex™ PF
9512
Versaflex™ CF
8888N-A
Versaflex™ PF
MD6666
Versaflex™ PF
MD6748
Versaflex™ PF
MD6700
Versaflex™ CF
9000
PP
PVC
Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 /
(Shore A) 50 49 35 37 38 35 37 31 30 19
MFI (190°C, 2.16kg)
(g/10min)
/ / / 15 5 15 20 3 5 27
MFI (230°C, 2.16kg) 8 20 8 / / / / / / /
1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um
(N/25mm)
25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3
75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 /
PMMA
(N/25mm)
25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9
75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /
https://www.avient.com/sites/default/files/2022-04/Versaflex XP Wet Grip Product Bulletin_NEW.pdf
Versaflex XP 2850
Hardness, Shore A 53
Specific Gravity 0.89
Color Natural
Tensile Strength (psi) 616.4
Elongation at Break (%) 541.4
Viscosity @ 11170/sec (Pa s) 10.9
Dry Kinetic COF 1.256
Wet Kinetic COF 2.463
Increase in COF* (%) 96.1
Abrasion Loss** (mg/cycle) 0.014
Bondability*** PP, PE
TECHNICAL PROPERTIES OF VERSAFLEX XP WET GRIP MATERIAL
* Pull time = 5 sec; Sled Weight = 203 grams; Rate = 30cm/min
** Weight = 1000 grams; Cycles = 500; Wheel = H-18
*** For bonding to other substrates, please contact Avient
COMPARING VERSAFLEX XP 2850 WITH COMMONLY USED WET GRIP MATERIALS
3.00
2.50
2.00
1.50
1.00
0.50
0.00
1.26
2.46
0.85
0.52
0.40
1.20
0.52 0.50 0.52 0.500.50 0.49
Wax Rubber EVA Foam Rubberized
Vinyl
Versaflex
XP 2850
PVC
DRY WET
Wet/Dry COF Performance
*Prepared to standard ASTM D1141-98R21
ps
i
D
ur
om
et
er
(S
ho
re
A
)
https://www.avient.com/sites/default/files/resources/PolyOne%25202012%2520Annual%2520Report.pdf
We believe these contracts should assure the availability of adequate amounts of
PVC resin and VCM.
We also believe that the pricing under these contracts provides PVC resins and
VCM to us at a competitive cost.
Fuller Company (a global
manufacturer and marketer of adhesives and specialty chemical products) from November 2005 to
April 2007.
https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
These highly biocompatible polymers will enhance our ability to help our customers accelerate speed-to-market, meet or exceed product performance requirements and navigate regulatory approvals more confidently,” said Mark Crist, president, PolyOne Distribution.
https://www.avient.com/investor-center/news/polyone-host-investor-conference-call
the time required to consummate the acquisition of Clariant's color and additive masterbatch business; the satisfaction or waiver of conditions in the purchase agreements; any material adverse changes in Clariant's color and additive masterbatch business; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed acquisition of Clariant's color and additive masterbatch business; our ability to achieve the strategic and other objectives relating to the proposed acquisition of Clariant's color and additive masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's color and additive masterbatch business and achieve the expected results of the acquisition of Clariant's color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/investor-center/news/polyone-announces-exercise-option-purchase-additional-common-shares
masterbatch business; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the acquisitions; our ability to achieve the strategic and other objectives relating to the acquisitions, including any expected synergies; our ability to successfully integrate
https://www.avient.com/investor-center/news/avient-completes-acquisition-dsm-protective-materials-dyneema
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to successfully integrate the Avient Protective Materials business and achieve the expected results of the business, including without limitation, the acquisition being accretive; any material adverse changes in the business supporting the Distribution assets being sold; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; our ability to achieve the strategic and other objectives relating to the Avient Protective Materials business and the proposed sale of the Distribution business; and other factors described in our Annual Report on Form 10-K for the year ended
https://www.avient.com/industries/healthcare/medical-devices-equipment/imaging-technology
Explore our solutions to help meet your design needs, performance criteria and regulatory approvals.